RLAY
Relay Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$3.23B
P/E Ratio
—
EPS
$-1.56
Beta
1.75
52W High
$17.47
52W Low
$2.98
50-Day MA
$14.01
200-Day MA
$9.08
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Relay Therapeutics Inc
Relay Therapeutics, Inc. is a clinical-stage precision drug company. The company is headquartered in Cambridge, Massachusetts.
Fundamentals
| Revenue (TTM) | $10.68M |
| Gross Profit (TTM) | $-245.58M |
| EBITDA | $-293.61M |
| Operating Margin | -2620.00% |
| Return on Equity | -40.00% |
| Return on Assets | -24.70% |
| Revenue/Share (TTM) | $0.06 |
| Book Value | $3.39 |
| Price-to-Book | 5.02 |
| Price-to-Sales (TTM) | 302.33 |
| EV/Revenue | 244.94 |
| EV/EBITDA | -0.80 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -60.90% |
| Shares Outstanding | $217.94M |
| Float | $136.02M |
| % Insiders | 1.39% |
| % Institutions | 86.98% |
Historical Volatility
HV 10-Day
83.96%
HV 20-Day
71.66%
HV 30-Day
61.57%
HV 60-Day
75.62%
HV Rank
29.0%
Volatility is currently expanding
Analyst Ratings
Consensus ($24.82 target)
2
Strong Buy11
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026